Abbreviated New Drug Application (ANDA): 207333
Company: LANNETT CO INC

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
OXYCODONE AND ACETAMINOPHEN	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325MG;5MG	TABLET;ORAL	Discontinued	None	No	No
OXYCODONE AND ACETAMINOPHEN	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325MG;10MG	TABLET;ORAL	Discontinued	None	No	No

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/25/2017	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/207333Orig1s000ltr.pdf

Action Date	Submission	Supplement Categories or Approval Type	Note
03/13/2024	SUPPL-12	Labeling-Package Insert, Labeling-Medication Guide	Label is not available on this site.
12/15/2023	SUPPL-11	Labeling-Package Insert	Label is not available on this site.
12/15/2023	SUPPL-10	Labeling-Package Insert, Labeling-Patient Package Insert	Label is not available on this site.
03/04/2021	SUPPL-7	Labeling-Package Insert, Labeling-Medication Guide	Label is not available on this site.
10/08/2019	SUPPL-6	Labeling-Medication Guide, Labeling-Package Insert	Label is not available on this site.
09/21/2018	SUPPL-4	Labeling-Package Insert	Label is not available on this site.
09/18/2018	SUPPL-3	REMS - PROPOSAL - D-N-A	Label is not available on this site.

FDA Approval for OXYCODONE AND ACETAMINOPHEN issued to LANNETT CO INC